Targeting the RUNX3–miR-186-3p–DAT–IGF1R axis as a therapeutic strategy in a Parkinson’s disease model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting the RUNX3–miR-186-3p–DAT–IGF1R axis as a therapeutic strategy in a Parkinson’s disease model ; volume:22 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-22 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (5.8.2024), 1-22, 12.2024
- Creator
-
Huang, Peng
Wan, Zhiting
Qu, Shaogang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05535-7
- URN
-
urn:nbn:de:101:1-2410252119559.723290593511
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huang, Peng
- Wan, Zhiting
- Qu, Shaogang
- SpringerLink (Online service)
Other Objects (12)
Disformal transformation in Newton–Cartan geometry
CD137 expression in cancer cells: regulation and significance
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
High cervical spinal cord stimulation in Parkinson’s disease with dopamine-resistant axial disabilities: a case with 2-year follow-up
LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis
Spinal cord stimulation for postural abnormalities in Parkinson’s disease: 1-year prospective pilot study
Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy
AVE0991 ameliorates dopaminergic neuronal damage in Parkinson’s disease through HOTAIRM1/miR-223-3p/α-synuclein axis
Recent Advances in Gold Nanorods‐Based Cancer Theranostics
The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
Disformal transformation in Newton–Cartan geometry
CD137 expression in cancer cells: regulation and significance
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
High cervical spinal cord stimulation in Parkinson’s disease with dopamine-resistant axial disabilities: a case with 2-year follow-up
LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis
Spinal cord stimulation for postural abnormalities in Parkinson’s disease: 1-year prospective pilot study
Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy
AVE0991 ameliorates dopaminergic neuronal damage in Parkinson’s disease through HOTAIRM1/miR-223-3p/α-synuclein axis
Recent Advances in Gold Nanorods‐Based Cancer Theranostics
The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
Disformal transformation in Newton–Cartan geometry
CD137 expression in cancer cells: regulation and significance
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells
High cervical spinal cord stimulation in Parkinson’s disease with dopamine-resistant axial disabilities: a case with 2-year follow-up
LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis
Spinal cord stimulation for postural abnormalities in Parkinson’s disease: 1-year prospective pilot study
Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy
AVE0991 ameliorates dopaminergic neuronal damage in Parkinson’s disease through HOTAIRM1/miR-223-3p/α-synuclein axis
Recent Advances in Gold Nanorods‐Based Cancer Theranostics